Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma

HIGHLIGHTS

• who: Laura J. Forker from the The University of Clinical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester , BX, UK have published the research: Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma, in the Journal: (JOURNAL) of 25/02/2022
• how: This study confirmed that the 24-gene hypoxia signature nanoString assay can be used in routine pre-treatment FFPE biopsies British Journal of Cancer alone or in conjunction with clinical risk factors to identify patients with a poor prognosis.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.